AMAG Pharmaceuticals, Inc. (AMAG) to Merge with Allos Therapeutics, Resulting Combination Projects Some $60M in Annual Cost Savings
AMAG Pharmaceuticals, well known as the biopharmaceutical company behind the FERAHEME® injection for treating iron deficiency anemia in adult chronic…